Labomar
A full-service CDMO for supplements, medical devices, and dermo-cosmetic products.
LBM | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0005421646
- LEI:
- 815600BD66DA7878FF03
- Country:
- Italy
- Address:
- VIA NAZARIO SAURO, 35/I, 31036 ISTRANA
- Website:
- https://labomar.com/en/
- Sector:
- Manufacturing
Description
Labomar is a Contract Development and Manufacturing Organization (CDMO) that specializes in creating and producing food supplements, medical devices, foods for special medical purposes (FSMPs), and dermo-cosmetic products. The company operates as a full-service, one-stop-shop partner, offering customized development of bespoke products and ready-to-market formulations. Labomar leverages patented and advanced technologies with a strong emphasis on scientific research and innovation to manufacture high-quality products. Its services cover the entire product lifecycle, from formulation and the production of plant extracts to manufacturing and regulatory support for its clients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-07-14 18:05 |
Comunicato ex art. 41, comma 2, lett. c) RE
|
Italian | 285.9 KB | ||
| 2023-07-13 18:21 |
Comunicato ex art. 41, comma 2, lett. c) RE
|
Italian | 285.4 KB | ||
| 2023-07-12 18:17 |
Comunicato ex art. 41, comma 2, lett. c) RE
|
Italian | 684.2 KB | ||
| 2023-07-11 18:26 |
Comunicato ex art. 41, comma 2, lett. c) RE
|
Italian | 683.1 KB | ||
| 2023-07-08 12:22 |
Pubblicazione del Documento di Offerta
|
Italian | 681.8 KB | ||
| 2023-07-07 20:59 |
Consob approva il Documento di Offerta
|
Italian | 681.8 KB | ||
| 2023-07-07 18:20 |
Comunicato ex art. 41, comma 2, lett. c) RE
|
Italian | 684.0 KB | ||
| 2023-07-06 18:30 |
Comunicato ex art. 41, comma 2, lett. c) RE_06.07.2023
|
Italian | 284.5 KB | ||
| 2023-07-05 18:25 |
Comunicato ex art. 41, comma 2, lett. c) RE
|
Italian | 284.5 KB | ||
| 2023-07-04 18:25 |
Comunicato ex art. 41, comma 2, lett. c) RE
|
Italian | 284.4 KB | ||
| 2023-07-03 20:10 |
Il Consiglio approva il Comunicato dell'Emittente
|
Italian | 890.0 KB | ||
| 2023-07-03 19:26 |
Comunicato art. 36, RE
|
Italian | 280.9 KB | ||
| 2023-07-03 18:46 |
Comunicato ex art. 41, comma 2, lett. c) RE_03.07.2023
|
Italian | 283.7 KB | ||
| 2023-07-03 16:21 |
Comunicato ai sensi dell’art. 38, comma 1, RE
|
Italian | 276.1 KB | ||
| 2023-07-01 18:41 |
Comunicato art. 36, RE
|
Italian | 675.9 KB |
Automate Your Workflow. Get a real-time feed of all Labomar filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Labomar
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Labomar via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
